Tag: drug discovery
Biobanking Infrastructure for High-Throughput Drug Discovery
Biobanks support pharmaceutical research by storing and managing biological samples, including blood, tissue, and cell lines, across early-stage compound screening and lead optimization.
As collections...
Regeneron Acquires 23andMe’s Biobank and Genetics Services for $256 Million to Advance Data-Driven Drug...
Highlights
Strategic Acquisition: Regeneron named successful bidder in 23andMe’s bankruptcy auction; deal valued at $256 million.
Consumer Genetics Continuity: 23andMe services to continue uninterrupted;...
World’s Largest ALS iPSC Biorepository Opens New Frontiers in Disease Research and Drug Discovery
Highlights
The new ALS biorepository offers the world’s largest collection of patient-specific iPSCs and multi-omics data for research.
Over 1,800 iPSC lines have already...
Biobank and Pharma Services now have Commercial Access to Lifespin’s Metabolic Profiler Software and...
Lifespin GmbH, based in Regensburg (Germany), with offices in Boston, Massachusetts, announced that it has launched a new commercial service for the pharmaceutical and...
New Freezing Technique for Ready-to-Use Cells in Research Validated by University of Warwick and...
A new technique for freezing cells for use in biomedical research, based on polymer technology developed at the University of Warwick, has been validated...
Stem Cell Banking: Current Trends, Benefits, Emerging Issues and Challenges
Recent scientific advancements have made stem cell therapy an emerging and promising area of research. The establishment of stem cell banks around the globe...
Sample Management Specialists Win Queen’s Award for Enterprise
UK Small Business Minister Paul Scully said "This country is renowned for its entrepreneurial achievements and there is no greater showcase for it than...
Lifebit and Boehringer Ingelheim Partner Up to Maximize the Value of Biobank Data for...
Computational science is revolutionizing the world in many ways. Hundreds of new fields and disciplines have emerged with countless opportunities and possibilities. The digital...
Datavant Partners with Nashville Biosciences to Accelerate Drug Discovery and Clinical Research
Nashville Biosciences, a wholly-owned subsidiary of Vanderbilt University Medical Center (VUMC) that leverages BioVU®, the medical center’s de-identified biobank to support biopharma research and...
Targeting CK1δ In Bladder Cancer
According to data from the US National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) program, the 5-year survival rates, 2000-2016, for invasive bladder...



















